NAVIDEA BIOPHARMACEUTICALS I's ticker is and the CUSIP is 63937X953. A total of 3 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $3,000 | -85.0% | 4,400 | -86.1% | 0.00% | – |
| Q4 2016 | $20,000 | -60.0% | 31,700 | -41.7% | 0.00% | -100.0% |
| Q3 2016 | $50,000 | +138.1% | 54,400 | +40.2% | 0.00% | – |
| Q2 2016 | $21,000 | -70.4% | 38,800 | -48.5% | 0.00% | -100.0% |
| Q1 2016 | $71,000 | +108.8% | 75,400 | +199.2% | 0.00% | – |
| Q4 2015 | $34,000 | -40.4% | 25,200 | +1.6% | 0.00% | -100.0% |
| Q3 2015 | $57,000 | +256.2% | 24,800 | +148.0% | 0.00% | – |
| Q2 2015 | $16,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q1 2015 | $16,000 | -95.9% | 10,000 | -95.2% | 0.00% | -100.0% |
| Q4 2014 | $391,000 | +26.9% | 207,100 | -11.3% | 0.01% | +20.0% |
| Q3 2014 | $308,000 | +22.2% | 233,600 | +37.2% | 0.01% | +25.0% |
| Q2 2014 | $252,000 | -42.1% | 170,300 | -27.5% | 0.00% | -42.9% |
| Q1 2014 | $435,000 | +40.3% | 234,900 | +56.8% | 0.01% | +40.0% |
| Q4 2013 | $310,000 | +248.3% | 149,800 | +347.2% | 0.01% | +150.0% |
| Q3 2013 | $89,000 | -47.0% | 33,500 | -46.9% | 0.00% | -50.0% |
| Q2 2013 | $168,000 | – | 63,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 54,400 | $50,000 | 0.00% |
| SIMPLEX TRADING, LLC | 37 | $1,000 | 0.00% |